This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Tumor BRCA testing in ovarian cancer and EQA scheme: our experience of a critical evaluation
Molecular Biology Reports Open Access 13 October 2021
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Feder, J.N. et al. Nature Genet. 13, 399– 408 (1996).
Jeffrey, G.P., Chakrabarti, S., Hegele, R.A. & Adams, P.C. Nature Genet. 22, 325–326 (1999).
Acknowledgements
We thank the other members of the ACMG/CAP Biochemical and Molecular Genetics Resource Committee, E. Grahek and other members of the CAP support staff, and all participating laboratories in the haemochromatosis proficiency testing program for assistance in the accrual of the survey data.
Author information
Authors and Affiliations
Corresponding author
Supplementary information
Rights and permissions
About this article
Cite this article
Noll, W., Belloni, D., Stenzel, T. et al. Polymorphism in intron 4 of HFE does not compromise haemochromatosis mutation results. Nat Genet 23, 271–272 (1999). https://doi.org/10.1038/15722
Issue Date:
DOI: https://doi.org/10.1038/15722
This article is cited by
-
Tumor BRCA testing in ovarian cancer and EQA scheme: our experience of a critical evaluation
Molecular Biology Reports (2021)
-
Experience and outcome of 3 years of a European EQA scheme for genetic testing of the spinocerebellar ataxias
European Journal of Human Genetics (2008)